About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Phenobarbital
- Procedure number
- PSUSA/00002370/202001
- Regulatory outcome
- Variation
Documents
Phenobarbital: List of nationally authorised medicinal products - PSUSA/00002370/202001
English (EN) (153.67 KB - PDF)
Phenobarbital: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002370/202001
English (EN) (83.26 KB - PDF)
български (BG) (72.54 KB - PDF)
español (ES) (41.01 KB - PDF)
čeština (CS) (312 KB - PDF)
dansk (DA) (90.95 KB - PDF)
Deutsch (DE) (106.03 KB - PDF)
eesti keel (ET) (56.75 KB - PDF)
ελληνικά (EL) (119.62 KB - PDF)
français (FR) (59.79 KB - PDF)
hrvatski (HR) (102.1 KB - PDF)
íslenska (IS) (30.56 KB - PDF)
italiano (IT) (177.02 KB - PDF)
latviešu valoda (LV) (112.19 KB - PDF)
lietuvių kalba (LT) (246.62 KB - PDF)
magyar (HU) (39.17 KB - PDF)
Malti (MT) (151.84 KB - PDF)
Nederlands (NL) (149.73 KB - PDF)
norsk (NO) (59.1 KB - PDF)
polski (PL) (122.67 KB - PDF)
português (PT) (117.75 KB - PDF)
română (RO) (145.13 KB - PDF)
slovenčina (SK) (145.05 KB - PDF)
slovenščina (SL) (81.66 KB - PDF)
Suomi (FI) (105.95 KB - PDF)
svenska (SV) (112.46 KB - PDF)